Adverse events6,064

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 6,064

Type	Event	Organ system	Group	Affected	At risk
other	Abdominal distension	Gastrointestinal disorders	Part A: 3 mg/kg Nivolumab	0	7
other	Abdominal distension	Gastrointestinal disorders	Part A PK: 3 mg/kg Nivolumab	0	6
other	Abdominal distension	Gastrointestinal disorders	Part B: 3 mg/kg Nivolumab	2	72
other	Abdominal distension	Gastrointestinal disorders	Part C: 1mg/kg Nivolumab and 1mg/kg Ipilimumab	0	6
other	Abdominal distension	Gastrointestinal disorders	Part C: 3mg/kg Nivolumab and 1mg/kg Ipilimumab	0	6
other	Abdominal distension	Gastrointestinal disorders	Part C PK: 3mg/kg Nivolumab and 1mg/kg Ipilimumab	0	6
other	Abdominal distension	Gastrointestinal disorders	Part D: 3mg/kg Nivolumab and 1mg/kg Ipilimumab	6	29
other	Abdominal distension	Gastrointestinal disorders	Part E: 1mg/kg Nivolumab and 3mg/kg Ipilimumab	3	8
other	Abdominal pain	Gastrointestinal disorders	Part A: 3 mg/kg Nivolumab	1	7
other	Abdominal pain	Gastrointestinal disorders	Part A PK: 3 mg/kg Nivolumab	2	6
other	Abdominal pain	Gastrointestinal disorders	Part B: 3 mg/kg Nivolumab	22	72
other	Abdominal pain	Gastrointestinal disorders	Part C: 1mg/kg Nivolumab and 1mg/kg Ipilimumab	1	6
other	Abdominal pain	Gastrointestinal disorders	Part C: 3mg/kg Nivolumab and 1mg/kg Ipilimumab	2	6
other	Abdominal pain	Gastrointestinal disorders	Part C PK: 3mg/kg Nivolumab and 1mg/kg Ipilimumab	1	6
other	Abdominal pain	Gastrointestinal disorders	Part D: 3mg/kg Nivolumab and 1mg/kg Ipilimumab	8	29
other	Abdominal pain	Gastrointestinal disorders	Part E: 1mg/kg Nivolumab and 3mg/kg Ipilimumab	6	8
other	Acidosis	Metabolism and nutrition disorders	Part A: 3 mg/kg Nivolumab	0	7
other	Acidosis	Metabolism and nutrition disorders	Part A PK: 3 mg/kg Nivolumab	1	6
other	Acidosis	Metabolism and nutrition disorders	Part B: 3 mg/kg Nivolumab	1	72
other	Acidosis	Metabolism and nutrition disorders	Part C: 1mg/kg Nivolumab and 1mg/kg Ipilimumab	0	6

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02304458/events

API reference For AI assistants

Adverse events6,064

Sources 3

Read this list from software.